Prognostic roles of dysregulated METTL3 protein expression in cancers and potential anticancer value by inhibiting METTL3 function.

Rong ZhaoJiaping ChenYangwei WangHan XiaoPeiyuan MeiWei LinMingxin DiaoShiwen HeYongde LiaoWangyang Meng

Published in: Fundamental & clinical pharmacology (2024)

METTL3 protein expression is associated with poor prognosis in most cancer types and could be a biomarker for OS. Further, METTL3 inhibition might be a potential treatment strategy for cancers.

Keyphrases

poor prognosis
long non coding rna
papillary thyroid
signaling pathway
human health
childhood cancer
young adults
combination therapy